Iclusig

Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.) delivered a letter to Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) President and CEO Paris Panayiotopoulos. The purpose of the letter is to request information as to why the company felt justified in boosting the price of its Iclusig (...

Drug pricing has been one of the central issues of the 2016 presidential campaign. There is currently a whirlwind of negative public sentiment swirling around controversial pricing practices of companies like Valeant Pharmaceuticals Intl Inc (NYSE: VRX), Mallinckrodt PLC (NYSE: MNK) and Mylan NV (...

Leerink’s Michael Schmidt noted that despite the recent outperformance, Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) shares were still trading at a discount to its commercial-stage oncology biotech peers, although the company’s top line was expected to grow at a 35 percent CAGR during...

U.S. stocks were mostly positive on the first trading session of June in which investors were left confused over ISM's May Manufacturing data which was revised twice. Both the S&P 500 and Dow Jones indices reached new highs. The S&P 500 index reached a new all time high of 1,925.88...

Here's a look at the top tickers trending on StockTwits.com. Teva Pharmaceutical: CEO hosts UK and Israeli leaders Teva Pharmaceuticals (NASDAQ: TEVA) announced a collaboration between Teva and the United Kingdom Government's National Health Service National Institute for Health Research (NIHR)...

Here's a look at the top tickers trending on StockTwits.com BlackBerry: Is the turnaround on track? BlackBerry (NASDAQ: BBRY) revealed its first Foxconn manufactured smartphone, the BlackBerry Z3. According to Techcrunch.com the phone is “a Nokia-like touchscreen smartphone with rounded sides, a...

Stocks traded mostly lower today as investors digested a new set of earnings that were disappointing. A mixed housing data and a consumer sentiment coming in lower than expected was enough to tame the bulls as major indices finished the day mixed. Markets will be closed on Monday for Martin...

Here's a look at the top tickers trending on StockTwits.com. Ariad Pharmaceuticals On Friday morning, Ariad Pharmaceuticals (NASDAQ: ARIA) announced the commercial availability of Iclusig for adult patients with refractory chronic myeloid leukemia and Philadelphia-chromosome positive acute...

Monday's trading session featured a plethora of analyst upgrades and downgrades. With little key economic data released, markets were relatively tame as major indices failing to meaningfully move in any one direction. The Senate appears to be set to officially Janet Yellen to lead the Federal...

Major indices received a boost in Friday's trading activity following a better than expected third quarter GDP. The surprising economic data is yet another key data that may suggests that the economy is healthy enough and could handle the Fed's recent decision to taper its bond buying program....

While not offering any specifics, investors seemed comfortable enough with Dennis Lockhart's comments to end the week on a positive note. While speaking to CNBC the Atlanta Fed chief commented that tapering will begin “when the economy is ready and when the market is ready.” Lockhart also noted...

Shares of Ariad Pharmaceuticals (NASDAQ: ARIA) surged Friday, after the company revealed advisors to European Union regulators believe the company's Iclusig cancer drug should stay on the European market. Iclusig is used to treat two rare types of leukemia. Iclusig is Ariad's only product and...